Genotype-guided antiretroviral regimens in children with multidrug-resistant HIV-1 infection

Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses

(2015) P. Rojas Sánchez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Virtual support for paediatric HIV treatment decision making

(2014) Kirsty Le Doare et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

(2014) G Tudor-Williams et al.   HIV MEDICINE

The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents

(2013) Annette H Sohn et al.   Journal of the International AIDS Society

Potent and Sustained Antiviral Response of Raltegravir-based Highly Active Antiretroviral Therapy in HIV Type 1-infected Children and Adolescents

(2011) Verónica Briz et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir

(2010) Michael Michael Neely   Therapeutics and Clinical Risk Management

Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus

(2009) Isabelle Thuret et al.   AIDS

Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents

(2009) Stéphane Blanche et al.   AIDS

Young People in the United Kingdom and Ireland with Perinatally Acquired HIV: The Pediatric Legacy For Adult Services

(2009) Caroline Foster et al.   AIDS PATIENT CARE AND STDS

Management of paediatric HIV-1 resistance

(2009) Ravindra K Gupta et al.   CURRENT OPINION IN INFECTIOUS DISEASES